Loading...
OS Therapies Inc (OSTX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is currently in a bearish technical trend, with no significant positive catalysts or trading signals to support an immediate purchase. Insider selling and weak financial performance further reduce its attractiveness.
The technical indicators show a bearish trend. The MACD is negative and expanding downward, RSI is neutral at 21.453, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 1.194 and resistance at 1.305.
NULL identified. The company has no recent news, and there are no significant positive trading trends or signals.
Insiders are selling heavily, with a 100.96% increase in selling activity over the last month. The stock's financial performance remains weak, with no revenue and a significant net income loss of -$6,879,530 in Q3 2025.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income loss of -$6,879,530 (improved by 139.27% YoY), and an EPS of -0.22 (up 57.14% YoY). Gross margin remains at 0%.
Lake Street analyst Chad Messer lowered the price target from $18 to $17 while maintaining a Buy rating. The firm notes one-time regulatory expenses but expects reduced burn in Q4 and into 2026.